Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - omega-3-acid ethyl esters 90, quantity: 1000 mg - capsule, soft - excipient ingredients: purified water; gelatin; glycerol; d-alpha-tocopherol - hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response. treatment is indicated for the following types of dyslipidaemia (fredrickson classification) only: -type iv & v as monotherapy and with close monitoring of ldl-c levels. - type iib as add-on therapy to statins, when control of triglycerides with statins has been shown to be insufficient. patients with higher baseline levels of triglycerides are more likely to exhibit a better response to omacor. omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). there are insufficient data to support the use in patients with secondary endogenous hypertriglyceridaemia including patients with diabetes mellitus.

Marekani - Kiingereza - NLM (National Library of Medicine)

remedyrepack inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg per dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules and should continue this diet during treatment with omega-3-acid ethyl esters capsules. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceri

Falme za Kiarabu - Kiingereza - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

vitamin a (833 iu), vitamin e, vitamin d (400 iu), omega-3 fatty acids (from fish oil 4.52g and cod liver oil 4.52g together providing epa 1240mg and dha 1090mg) -

Falme za Kiarabu - Kiingereza - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

omega-3 fatty acids (providing eicosapentaenoic acid 450mg and docosahexaenoic acid 590mg), vitamin e, vitamin a (833 iu), vitamin d (400 iu) -

Falme za Kiarabu - Kiingereza - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

vitamin d (400 iu), omega-3 fatty acids (providing eicosapentaenoic acid 52mg and docosahexaenoic acid 260mg), vitamin e -

Falme za Kiarabu - Kiingereza - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

omega-3 fatty acids ( epa 360mg, dha 240mg) -

India - Kiingereza - Central Drugs Standard Control Organization

merck - omega 3 fatty acids,vit.e,germ oil - cap - 30mg,200iu.,100mg - 5*10

India - Kiingereza - Central Drugs Standard Control Organization

merck - omega 3 fatty acids,vit.e,germ oil - cap - 30mg,400iu.,100mg - 5*10

Marekani - Kiingereza - NLM (National Library of Medicine)

fresenius kabi usa, llc - fish oil (unii: xgf7l72m0f) (fish oil - unii:xgf7l72m0f) - omegaven is indicated as a source of calories and fatty acids in pediatric patients with parenteral nutrition-associated cholestasis (pnac). limitations of use: - omegaven is not indicated for the prevention of pnac. it has not been demonstrated that omegaven prevents pnac in parenteral nutrition (pn)-dependent patients [see clinical studies (14)]. - it has not been demonstrated that the clinical outcomes observed in patients treated with omegaven are a result of the omega-6:omega-3 fatty acid ratio of the product [see clinical studies (14)]. use of omegaven is contraindicated in patients with: - known hypersensitivity to fish or egg protein or to any of the active ingredients or excipients [see warnings and precautions (5.2)]. - severe hemorrhagic disorders due to a potential effect on platelet aggregation. - severe disorders of lipid metabolism characterized by hypertriglyceridemia (serum triglyceride concentrations greater than 1,000 mg/dl) [see warnings and precautions (5.6)]. risk summary there are no av

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

b & n global pty ltd - natural fish oil, quantity: 1000 mg (equivalent: eicosapentaenoic acid, qty 180 mg; equivalent: docosahexaenoic acid, qty 120 mg) - capsule, soft - excipient ingredients: purified water; d-alpha-tocopherol; gelatin; glycerol - * rhar ? temporary relief of the pain of rheumatoid arthritis. * rheum ? temporary relief of the pain of rheumatism or temporary relief of rheumatic pain. * rheum2 ? symptomatic relief of rheumatism. * arth2 - may help reduce joint inflammation associated with arthritis. * arth3 - may help reduce joint swelling associated with arthritis. * arth4 ? may help increase joint mobility associated with arthritis. * rheum4 ? may assist in the management of rheumatism. * arth1 - for the relief of pain of arthritis or temporary relief of arthritic pain. * supports the health of the joints. * supports healthy joint function. * assists in maintaining joint mobility. * provides an anti-inflammatory action within the body which may help reduce inflammation and joint swelling associated with arthritis. * skin1 ? for the symptomatic relief of eczema. * skin9 ? may assist in the management of eczema. * maintains healthy skin. * skin10 ? may assist in the management of psoriasis. * skin11 ? may assist in the management of dermatitis. * skin12 ? may assist in the management of dry skin. * skin2 ? for the symptomatic relief of psoriasis. * skin3 ? for the symptomatic relief of dermatitis. * skin4 ? for the symptomatic relief of dry skin. * supports/maintains the health of the cardiovascular system. * omega 3 fatty acids are important for cardiovascular health. * maintains the health of the heart. * maintains normal healthy brain function. * supports brain health. * supports the maintenance of healthy mood. * helps to maintain healthy cognitive function. * may help maintain healthy (and or normal) cholesterol levels. * may help to maintain cholesterol levels within the normal (and or healthy) range and improve hdl:ldl ratio. * maintains normal healthy nervous system. * a natural source of marine omega 3 fatty acids. * omega 3 fatty acids are very important as the body cannot produce them and they can therefore only obtain them from the diet. * polyunsaturated fatty acids, such as those found in fish oil, are used in the body in the manufacture of prostaglandins. * the essential fatty acids in fish oil are essential for the healthy function of the eye. * well ? aids, assists or helps in the maintenance or improvement of general wellbeing.